Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH25012D
  • |
  • Pages: 87
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for insurance operations in all the 50 states of the US. Anthem is headquartered in Indianapolis, Indiana, the US.

Anthem Inc (ANTM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10

Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Anthem Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Linkwell Health Raises USD 11 Million In Series C Financing 12

Private Equity 13

LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13

Partnerships 14

Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14

New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15

Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16

Debt Offering 17

Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17

Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18

Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19

Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20

Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21

WellPoint Completes Private Placement Of Debentures Due 2042 For USD 1.5 Billion 22

WellPoint Completes Public Offering Of Notes Due 2043 For USD 1 Billion 24

WellPoint Completes Public Offering Of Notes Due 2015 For USD 625 Million 26

WellPoint Completes Public Offering Of Notes Due 2018 For USD 625 Million 28

WellPoint Completes Public Offering Of Notes Due 2023 For USD 1 Billion 30

WellPoint Completes Public Offering Of Senior Notes Due 2022 For USD 850 Million 32

WellPoint Completes Public Offering Of Senior Notes Due 2042 For USD 900 Million 33

Acquisition 34

HealthCore Acquires New England Research Institutes (NERI) 34

Anthem Acquires Simply Healthcare 35

WellPoint Completes Acquisition Of Amerigroup For USD 4.9 Billion 36

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38

Amerigroup Acquires Health Plus From Lutheran Medical Center For USD 85 Million 39

Anthem Inc-Key Competitors 41

Anthem Inc-Key Employees 42

Anthem Inc-Locations And Subsidiaries 43

Head Office 43

Other Locations & Subsidiaries 43

Recent Developments 46

Financial Announcements 46

Oct 31, 2018: Anthem reports third quarter 2018 results reflecting strengthening operating performance 46

Jul 25, 2018: Anthem reports second quarter 2018 results reflecting strong overall enterprise-wide execution 48

Apr 25, 2018: Anthem Reports First Quarter 2018 Results Reflecting Strong Medical Cost Performance 50

Jan 31, 2018: Anthem Reports Fourth Quarter and Full Year 2017 Results Reflecting Balanced Performance across Its Business Units 52

Oct 25, 2017: Anthem Reports Third Quarter 2017 Results 55

Jul 26, 2017: Anthem Reports Second Quarter 2017 Results 58

Apr 26, 2017: Anthem Reports First Quarter 2017 Results 60

Feb 01, 2017: Anthem Reports Fourth Quarter and Full Year 2016 Results 63

Corporate Communications 64

May 10, 2018: Chief Operating Officer Deepti Jain to Lead IngenioRx 64

Feb 22, 2018: Anthem Board of Directors Names Elizabeth E. Tallett as Independent Chairman of the Board 65

Jan 31, 2018: Anthem Appoints Bahija Jallal As New Director 66

Dec 07, 2017: Anthem's Board Welcomes Antonio Neri as New Director 67

Nov 16, 2017: Anthem Names Greg Poulakos President of Anthem Life & Disability Business 68

Nov 06, 2017: Anthem Announces Key Management Changes 69

Aug 30, 2017: Anthem Names Tomas Orozco President of Medicare East Region 70

Aug 24, 2017: Anthem Names Jacquelyn H. Wolf as Executive Vice President, Chief Human Resources Officer 71

Legal and Regulatory 72

Oct 15, 2018: Anthem Pays OCR USD 16 Million in Record HIPAA Settlement Following Largest U.S. Health Data Breach in History 72

Apr 28, 2017: Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna 73

Feb 09, 2017: Anthem Responds to U.S. District Court's Decision on Acquisition of Cigna 74

Government and Public Interest 75

Sep 25, 2018: NORD Receives Grant from Anthem Foundation for Expansion of Rare Disease Database 75

Sep 20, 2018: March Of Dimes receives USD 1.5 million grant from The Anthem Foundation 76

Sep 05, 2018: National Council on Aging awarded grant from the Anthem Foundation to bring aging mastery to thousands of older adults 77

Sep 07, 2017: Anthem: Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug 78

Aug 23, 2017: Anthem Reaches Goal Two Years Early for Health Plans to Reduce Opioids Filled at Pharmacy by 30 Percent 79

Product News 80

Nov 08, 2017: Anthem Health Plans Play Major Role in Trial to Determine Best Aspirin Dose to Prevent Heart Attacks and Strokes 80

Other Significant Developments 81

Oct 11, 2018: Anthem activates plan to help residents impacted by Hurricane Michael 81

Sep 13, 2018: Anthem activates plan to help residents in states impacted by hurricane florence 82

Jun 12, 2018: Anthem Blue Cross and Blue Shield Adds Decatur County Memorial Hospital to Its Medicare Advantage Provider Network 83

May 22, 2018: Anthem Announces Plans to Remain Headquartered in Indianapolis 84

Oct 18, 2017: Anthem Launches IngenioRx, New Pharmacy Benefits Manager 85

Sep 21, 2017: UniCare Health Plan in West Virginia Takes Action to Help Treat Substance Use Disorder Across the State 86

Appendix 87

Methodology 87

About GlobalData 87

Contact Us 87

Disclaimer 87

List of Figures

Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Anthem Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Anthem Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10

Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Linkwell Health Raises USD 11 Million In Series C Financing 12

LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13

Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14

New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15

Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16

Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17

Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18

Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19

Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20

Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21

WellPoint Completes Private Placement Of Debentures Due 2042 For USD 1.5 Billion 22

WellPoint Completes Public Offering Of Notes Due 2043 For USD 1 Billion 24

WellPoint Completes Public Offering Of Notes Due 2015 For USD 625 Million 26

WellPoint Completes Public Offering Of Notes Due 2018 For USD 625 Million 28

WellPoint Completes Public Offering Of Notes Due 2023 For USD 1 Billion 30

WellPoint Completes Public Offering Of Senior Notes Due 2022 For USD 850 Million 32

WellPoint Completes Public Offering Of Senior Notes Due 2042 For USD 900 Million 33

HealthCore Acquires New England Research Institutes (NERI) 34

Anthem Acquires Simply Healthcare 35

WellPoint Completes Acquisition Of Amerigroup For USD 4.9 Billion 36

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38

Amerigroup Acquires Health Plus From Lutheran Medical Center For USD 85 Million 39

Anthem Inc, Key Competitors 41

Anthem Inc, Key Employees 42

Anthem Inc, Subsidiaries 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Anthem Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17815
Site License
USD 500 INR 35630
Corporate User License
USD 750 INR 53445

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com